1980
DOI: 10.1016/s0161-4630(80)80004-8
|View full text |Cite
|
Sign up to set email alerts
|

Decrease of eicosapentaenoic acid in fatty liver of diabetic subjects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1983
1983
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…Noteworthy, this was associated with increased liver p‐Akt/Akt ratio, a component of intracellular insulin signaling pathway that acts as inducer of de novo lipogenesis, such findings that may be explained by the high insulin levels found in lipoatrophic mice . This enhanced de novo lipogenesis was associated with liver depletion of n ‐3 PUFA EPA and DHA, such a phenotype that is commonly found in the liver of cirrhotic, diabetic, and NAFLD patients and seems to be inversely related to hepatocyte lipid deposition, ballooning, and macrovesicular steatosis . Supporting this notion, intake of HFO increased liver content of EPA and DHA, inhibited FAS activity, and reduced hepatic steatosis and ballooning, indicating that n ‐3 fatty acids regulate lipid droplet formation and deposition in hepatocytes .…”
Section: Discussionmentioning
confidence: 68%
“…Noteworthy, this was associated with increased liver p‐Akt/Akt ratio, a component of intracellular insulin signaling pathway that acts as inducer of de novo lipogenesis, such findings that may be explained by the high insulin levels found in lipoatrophic mice . This enhanced de novo lipogenesis was associated with liver depletion of n ‐3 PUFA EPA and DHA, such a phenotype that is commonly found in the liver of cirrhotic, diabetic, and NAFLD patients and seems to be inversely related to hepatocyte lipid deposition, ballooning, and macrovesicular steatosis . Supporting this notion, intake of HFO increased liver content of EPA and DHA, inhibited FAS activity, and reduced hepatic steatosis and ballooning, indicating that n ‐3 fatty acids regulate lipid droplet formation and deposition in hepatocytes .…”
Section: Discussionmentioning
confidence: 68%
“…Interestingly, it has long been known that EPA can be found in low amounts in the fatty liver of diabetic patients [140]. A study carried out on myotubes prepared using cells obtained from obese type 2 diabetic patients have shown an impaired mitochondrial capacity for fatty acid and glucose oxidation.…”
Section: Activity Of Long-chain Polyunsaturated Fatty Acids (Pufas)mentioning
confidence: 99%